Cost-effectiveness of a central venous catheter care bundle

PLoS ONE

Volumn 5, Issue 9, 2010, Pages 1-11

  Halton, Kate A ^a,b   Cook, David ^c   Paterson, David L ^a,d   Safdar, Nasia ^e   Graves, Nicholas ^a,b  

^a Centre for Healthcare Related Infection Surveillance and Prevention   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; FLUCONAZOLE; MINOCYCLINE; RIFAMYCIN; SULFADIAZINE SILVER; TIMENTIN; VANCOMYCIN;

ARTICLE; AUSTRALIA; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG COST; ECONOMIC EVALUATION; HEALTH ECONOMICS; HUMAN; INFECTION CONTROL; INFECTION RISK; PATIENT CARE; RISK REDUCTION; SENSITIVITY ANALYSIS; STATISTICAL MODEL; AGED; CENTRAL VENOUS CATHETERIZATION; CROSS INFECTION; ECONOMICS; FEMALE; INTENSIVE CARE; MALE; MIDDLE AGED;

AGED; AGED, 80 AND OVER; AUSTRALIA; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; COST-BENEFIT ANALYSIS; CROSS INFECTION; FEMALE; HUMANS; INTENSIVE CARE; MALE; MIDDLE AGED;

EID: 77958605348     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012815     Document Type: Article

References (45)

1. Blot SI, Depuydt P, Annemans L, Benoit D, Hoste E, et al. (2005) Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clinical Infectious Diseases 41: 1591-1598.
2. Harbarth S, Sax H, Gastmeier P (2003) The preventable proportion of nosocomial infections: an overview of published reports. Journal of Hospital Infection 54: 258-266.
3. Berwick DM, Calkins DR, McCannon CJ, Hackbarth AD (2006) The 100,000 Lives Campaign: Setting a goal and a deadline for improving health care quality. JAMA 295: 324-327.
4. Centers for Medicare & Medicaid Services (2008) Medicare Program: Changes to the hospital inpatient prospective payment systems and fiscal year 2009 rates; payments for graduate medical education in certain emergency situations; changes to disclosure of physician ownership in hospitals and physician selfreferral rules; updates to the long-term care prospective payment system; updates to certain IPPS-excluded hospitals; and collection of information regarding financial relationships between hospitals; final rule. Federal Register 73: 48434-49083.
5. Graves N, McGowan JE Jr. (2008) Nosocomial infection, the Deficit Reduction Act, and incentives for hospitals. JAMA 300: 1577-1579.
6. Centers for Disease Control and Prevention (2002) Guidelines for the prevention of intravascular catheter-related infections. MMWR; Morbidity and mortality weekly report 51: 1-29.
7. Gastmeier P, Geffers C (2006) Prevention of catheter-related bloodstream infections: analysis of studies published between 2002 and 2005. Journal of Hospital Infection 64: 326-335.
8. Halton KA, Graves N (2007) Economic evaluation and catheter-related bloodstream infections. Emerging Infectious Diseases 13: 815-823.
9. Berenholtz SM, Pronovost PJ, Lipsett PA, Hobson D, Earsing K, et al. (2004) Eliminating catheter-related bloodstream infections in the intensive care unit. Critical Care Medicine 32: 2014-2020.
10. (2005) Reduction in central line-associated bloodstream infections among patients in intensive care units - Pennsylvania, April 2001 - March 2005. MMWR; Morbidity and Mortality Weekly Report 54: 1013-1016.
11. Ramritu P, Halton KA, Collignon PJ, Cook D, Fraenkel D, et al. (2008) A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units. American Journal of Infection Control 36: 104-117.
12. Halton KA, Cook DA, Whitby M, Paterson DL, Graves N (2009) Costeffectiveness of antimicrobial catheters in the intensive care unit: addressing uncertainty in the decision. Critical Care 13: R35.
13. Oda T, Hamasaki J, Kanda N, Mikami K (1997) Anaphylactic shock induced by an antiseptic-coated central venous [correction of nervous] catheter. Anesthesiology 87: 1242-1244.
14. McConnell SA, Gubbins PO, Anaissie EJ (2003) Do antimicrobial-impregnated central venous catheters prevent catheter-related bloodstream infection? Clinical Infectious Diseases 37: 65-72.
15. Bolz K, Ramritu P, Halton K, Cook D, Graves N (2008) Management of central venous catheters in adult intensive care units in Australia: policies and practices. Healthcare Infection 13: 48-55.
16. Gold MR, Siegel JE, Russell LB, et al. (1996) Cost-Effectiveness in Health and Medicine. New York: Oxford University Press.
17. Cooper NJ, Coyle D, Abrams KR, Mugford M, Sutton AJ (2005) Use of evidence in decision models: an appraisal of health technology assessments in the UK since 1997. Journal of Health Services Research and Policy 10: 245-250.
18. Martin J, Anderson T, Turton C, Hart GK, Hicks P (2006) Intensive Care Resources & Activity: Australia & New Zealand 2003-2005. Melbourne: ANZICS.
19. McLaws ML, Berry G (2005) Nonuniform risk of bloodstream infection with increasing central venous catheter-days. Infection Control and Hospital Epidemiology 26: 715-719.
20. Morton AP, Clements AC, Doidge S, Stackelroth J, Curtis M, et al. (2008) Surveillance of healthcare-acquired infections in Queensland, Australia: data and lessons from the first 5 years. Infection Control and Hospital Epidemiology 29: 695-701.
21. Warren DK, Quadir WW, Hollenbeak CS, Elward AM, Cox MJ, et al. (2006) Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital. Critical care medicine 34: 2084-2089.
22. Williams TA, Dobb GJ, Finn JC, Knuiman M, Lee KY, et al. (2006) Data linkage enables evaluation of long-term survival after intensive care. Anaesthesia and Intensive Care 34: 307-315.
23. Australian Institute of Health and Welfare (2006) Australia's Health 2006. AIHW cat. no. AUS 73. Canberra: AIHW.
24. Cuthbertson BH, Scott J, Strachan M, Kilonzo M, Vale L (2005) Quality of life before and after intensive care. Anaesthesia 60: 332-339.
25. Dowdy DW, Eid MP, Sedrakyan A, Mendez-Tellez PA, Pronovost PJ, et al. (2005) Quality of life in adult survivors of critical illness: a systematic review of the literature. Intensive Care Medicine 31: 611-620.
26. Hawthorne G, Osborne R (2005) Population norms and meaningful differences for the Assessment of Quality of Life (AQoL) measure. Australian and New Zealand Journal of Public Health 29: 136-142.
27. Bureau of Labor Statistics Consumer Price Index.
28. Rechner IJ, Lipman J (2005) The costs of caring for patients in a tertiary referral Australian Intensive Care Unit. Anaesthesia and Intensive Care 33: 477-482.
29. Graves N, Birrell FA, Whitby M (2005) Modeling the economic losses from pressure ulcers among hospitalised patients in Australia. Wound Repair and Regeneration 13: 462-467.
30. Aboelela SW, Stone PW, Larson EL (2007) Effectiveness of bundled behavioural interventions to control healthcare-associated infections: a systematic review of the literature. Journal of Hospital Infection 66: 101-108.
31. Pronovost PJ, Needham DM, Berenholtz S, Sinopoli D, Chu H, et al. (2006) An intervention to decrease catheter-related bloodstream infections in the ICU. New England Journal of Medicine 355: 2725-2732.
32. Pronovost PJ, Berenholtz S, Dorman T, Lipsett PA, Simmonds T, et al. (2003) Improving communication in the ICU using daily goals. Journal of Critical Care 18: 71-75.
33. Pronovost PJ, Weast B, Bishop K, Paine L, Griffith R, et al. (2004) Senior executive adopt-a-work unit: a model for safety improvement. Joint Commission Journal on Quality and Patient Safety 30: 59-68.
34. Pronovost PJ, Weast B, Rosenstein B, Sexton B, Holzmueller CG, et al. (2005) Implementing and validating a comprehensive unit-based safety program. Journal of Patient Safety 1: 33-40.
35. Pronovost PJ, Goeschel C (2005) Improving ICU care: it takes a team. Healthcare Executive 20: 15-22.
36. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL (2005) Critical assessment of economic evaluation. Methods for the Economic Evaluation of Health Care Programmes. 3rd ed. New York: Oxford University Press. pp 27-53.
37. Shiroiwa T, Sung Y, Fukuda T, Lang H, Bae S, et al. (2009) International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost-effectiveness? Health Economics: [Epub ahead of print].
38. Kahn JM, Rubenfeld GD, Rohrbach J, Fuchs BD (2008) Cost savings attributable to reductions in intensive care unit length of stay for mechanically ventilated patients. Medical Care 46: 1226-1233.
39. Graves N, Halton KA, Lairson D (2007) Economics and preventing hospitalacquired infection - broadening the perspective. Infection Control and Hospital Epidemiology 28: 178-184.
40. Roberts RR, Frutos PW, Ciavarella GC, Gussow LM, Mansah EK, et al. (1999) Distribution of fixed v. variable costs of hospital care. JAMA 281: 644-649.
41. Graves N (2004) Economics and preventing hospital-acquired infection. Emerging Infectious Diseases 10: 561-566.
42. Graves N, Halton K, Robertus L (2008) Costs of healthcare associated infection. In: Cruickshank M, Ferguson J, eds. Reducing Harm to Patients from Health Care Associated Infection: The Role of Surveillance. Sydney: Australian Commission on Safety and Quality in Health Care.
43. Ward WJJ, Spragens L, Smithson K (2006) Building the business case for clinical quality. Healthcare Financial Management 60: 92-98.
44. George B, Harris A, Mitchell A (2001) Cost-effectiveness analysis and the consistency of decision making: evidence from pharmaceutical reimbursement in Australia (1991 to 1996). Pharmacoeconomics 19: 1103-1109.
45. Devlin N, Parkin D (2004) Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis. Health Economics 13: 437-452